InnoCan Pharma's total assets for Q4 2023 were $6.94M, an increase of 1.08% from the previous quarter. INNPF total liabilities were $2.55M for the fiscal quarter, a 7.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.